Table 3.
SYNE1 and FOXE1 | ||
---|---|---|
Patient group | Positive | Sensitivity |
Stage I | 10/27 | 37% |
Stage II | 13/15 | 87% |
Stage III | 11/20 | 55% |
Stage IV | 4/4 | 100% |
Case total | 38/66 | 58% |
Specificity | ||
Control | 21/240 | 91% |
SYNE1 and FOXE1 | ||
---|---|---|
Patient group | Positive | Sensitivity |
Stage I | 10/27 | 37% |
Stage II | 13/15 | 87% |
Stage III | 11/20 | 55% |
Stage IV | 4/4 | 100% |
Case total | 38/66 | 58% |
Specificity | ||
Control | 21/240 | 91% |